Great Lakes Advisors, Llc
Source: SEC Form 13F · as of Mar 2026Great Lakes Advisors, Llc holds 23 biotech & pharma companies tracked by BioSniper, totaling $218.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
23
Total value held
$218.9M
BioSniper AIPage context preserved
Prepared research question
What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 1,089,487 | $151.8M |
| JAZZJazz Pharmaceuticals plc | 48,945 | $9.3M |
| IONSIONIS PHARMACEUTICALS INC | 118,926 | $8.9M |
| REGNREGENERON PHARMACEUTICALS, INC. | 10,232 | $7.9M |
| PTGXProtagonist Therapeutics, Inc | 71,043 | $7.5M |
| ACADACADIA PHARMACEUTICALS INC | 241,827 | $5.4M |
| ANIPANI PHARMACEUTICALS INC | 67,130 | $5.2M |
| DNLIDenali Therapeutics Inc. | 227,110 | $4.4M |
| ROIVRoivant Sciences Ltd. | 135,498 | $3.8M |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 55,022 | $3.0M |
| KURAKura Oncology, Inc. | 339,599 | $2.8M |
| SUPNSUPERNUS PHARMACEUTICALS, INC. | 48,180 | $2.5M |
| CYTKCYTOKINETICS INC | 24,981 | $1.6M |
| AXSMAxsome Therapeutics, Inc. | 6,730 | $1.1M |
| HROWHARROW, INC. | 26,963 | $951K |
| TGTXTG THERAPEUTICS, INC. | 17,939 | $596K |
| INCYIncyte Corp. | 5,817 | $547K |
| TRDAEntrada Therapeutics, Inc. | 41,531 | $524K |
| PRTAPROTHENA CORP PUBLIC LTD CO | 29,593 | $288K |
| BIOABioAge Labs, Inc. | 15,932 | $279K |
| NKTRNEKTAR THERAPEUTICS | 3,741 | $269K |
| CGEMCullinan Therapeutics, Inc. | 11,806 | $168K |
| TVRDTvardi Therapeutics, Inc. | 36,236 | $115K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.